161 related articles for article (PubMed ID: 10556039)
21. One INK4 gene and no ARF at the Fugu equivalent of the human INK4A/ARF/INK4B tumour suppressor locus.
Gilley J; Fried M
Oncogene; 2001 Nov; 20(50):7447-52. PubMed ID: 11704876
[TBL] [Abstract][Full Text] [Related]
22. Structure of the cyclin-dependent kinase inhibitor p19Ink4d.
Luh FY; Archer SJ; Domaille PJ; Smith BO; Owen D; Brotherton DH; Raine AR; Xu X; Brizuela L; Brenner SL; Laue ED
Nature; 1997 Oct; 389(6654):999-1003. PubMed ID: 9353127
[TBL] [Abstract][Full Text] [Related]
23. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
Haviernik P; Schmidt M; Hu X; Wolff L
Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
[TBL] [Abstract][Full Text] [Related]
24. p18(INK4c) collaborates with other CDK-inhibitory proteins in the regenerating liver.
Luedde T; Rodriguez ME; Tacke F; Xiong Y; Brenner DA; Trautwein C
Hepatology; 2003 Apr; 37(4):833-41. PubMed ID: 12668976
[TBL] [Abstract][Full Text] [Related]
25. INK4 cell cycle inhibitors direct transcriptional inactivation of NF-kappaB.
Wolff B; Naumann M
Oncogene; 1999 Apr; 18(16):2663-6. PubMed ID: 10353611
[TBL] [Abstract][Full Text] [Related]
26. Expression of INK4 inhibitors of cyclin D-dependent kinases during mouse brain development.
Zindy F; Soares H; Herzog KH; Morgan J; Sherr CJ; Roussel MF
Cell Growth Differ; 1997 Nov; 8(11):1139-50. PubMed ID: 9372237
[TBL] [Abstract][Full Text] [Related]
27. Molecular analysis of a family of cyclin-dependent kinase inhibitor genes (p15/MTS2/INK4b and p18/INK4c) in non-small cell lung cancers.
Kawamata N; Miller CW; Koeffler HP
Mol Carcinog; 1995 Dec; 14(4):263-8. PubMed ID: 8519415
[TBL] [Abstract][Full Text] [Related]
28. Intragenic mutations of the p16(INK4), p15(INK4B) and p18 genes in primary non-small-cell lung cancers.
Rusin MR; Okamoto A; Chorazy M; Czyzewski K; Harasim J; Spillare EA; Hagiwara K; Hussain SP; Xiong Y; Demetrick DJ; Harris CC
Int J Cancer; 1996 Mar; 65(6):734-9. PubMed ID: 8631583
[TBL] [Abstract][Full Text] [Related]
29. Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood.
Takeuchi S; Bartram CR; Seriu T; Miller CW; Tobler A; Janssen JW; Reiter A; Ludwig WD; Zimmermann M; Schwaller J
Blood; 1995 Jul; 86(2):755-60. PubMed ID: 7606004
[TBL] [Abstract][Full Text] [Related]
30. Stability and folding of the tumour suppressor protein p16.
Tang KS; Guralnick BJ; Wang WK; Fersht AR; Itzhaki LS
J Mol Biol; 1999 Jan; 285(4):1869-86. PubMed ID: 9917418
[TBL] [Abstract][Full Text] [Related]
31. Control of spermatogenesis in mice by the cyclin D-dependent kinase inhibitors p18(Ink4c) and p19(Ink4d).
Zindy F; den Besten W; Chen B; Rehg JE; Latres E; Barbacid M; Pollard JW; Sherr CJ; Cohen PE; Roussel MF
Mol Cell Biol; 2001 May; 21(9):3244-55. PubMed ID: 11287627
[TBL] [Abstract][Full Text] [Related]
32. The nuclear protein p34SEI-1 regulates the kinase activity of cyclin-dependent kinase 4 in a concentration-dependent manner.
Li J; Melvin WS; Tsai MD; Muscarella P
Biochemistry; 2004 Apr; 43(14):4394-9. PubMed ID: 15065884
[TBL] [Abstract][Full Text] [Related]
33. INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions.
Cánepa ET; Scassa ME; Ceruti JM; Marazita MC; Carcagno AL; Sirkin PF; Ogara MF
IUBMB Life; 2007 Jul; 59(7):419-26. PubMed ID: 17654117
[TBL] [Abstract][Full Text] [Related]
34. Biochemical characterization of p16INK4- and p18-containing complexes in human cell lines.
Ragione FD; Russo GL; Oliva A; Mercurio C; Mastropietro S; Pietra VD; Zappia V
J Biol Chem; 1996 Jul; 271(27):15942-9. PubMed ID: 8663131
[TBL] [Abstract][Full Text] [Related]
35. Lack of effect of extremely low frequency electromagnetic fields on cyclin-dependent kinase 4 inhibitor gene p18(INK4C) in electric energy workers.
Erdal N; Erdal ME; Gürgül S
Arch Med Res; 2005; 36(2):120-3. PubMed ID: 15847943
[TBL] [Abstract][Full Text] [Related]
36. Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1.
Zhang S; Ramsay ES; Mock BA
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2429-34. PubMed ID: 9482902
[TBL] [Abstract][Full Text] [Related]
37. Structural characterization of the tumor suppressor p16, an ankyrin-like repeat protein.
Boice JA; Fairman R
Protein Sci; 1996 Sep; 5(9):1776-84. PubMed ID: 8880901
[TBL] [Abstract][Full Text] [Related]
38. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging.
Zindy F; Quelle DE; Roussel MF; Sherr CJ
Oncogene; 1997 Jul; 15(2):203-11. PubMed ID: 9244355
[TBL] [Abstract][Full Text] [Related]
39. RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors.
Zhang S; Tang Q; Xu F; Xue Y; Zhen Z; Deng Y; Liu M; Chen J; Liu S; Qiu M; Liao Z; Li Z; Luo D; Shi F; Zheng Y; Bi F
Mol Cancer Res; 2009 Apr; 7(4):570-80. PubMed ID: 19372585
[TBL] [Abstract][Full Text] [Related]
40. Frequent inactivation of the cyclin-dependent kinase inhibitor p18 by homozygous deletion in multiple myeloma cell lines: ectopic p18 expression inhibits growth and induces apoptosis.
Kulkarni MS; Daggett JL; Bender TP; Kuehl WM; Bergsagel PL; Williams ME
Leukemia; 2002 Jan; 16(1):127-34. PubMed ID: 11840272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]